Richard A. Schnizer

Array ( [id] => 10297624 [patent_doc_number] => 20150182623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'Compositions Comprising an Anti-PDGF Aptamer and a VEGF Antagonist' [patent_app_type] => utility [patent_app_number] => 14/554894 [patent_app_country] => US [patent_app_date] => 2014-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 98 [patent_figures_cnt] => 98 [patent_no_of_words] => 49409 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14554894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11084158 [patent_doc_number] => 20160281123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'METHOD FOR PRODUCING RNA MEMBRANE AND RNA MEMBRANE PROCUCED THEREBY' [patent_app_type] => utility [patent_app_number] => 15/035747 [patent_app_country] => US [patent_app_date] => 2014-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 3748 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11727999 [patent_doc_number] => 20170189441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES AND PEPTIDE CONTAINING CONJUGATES' [patent_app_type] => utility [patent_app_number] => 15/033715 [patent_app_country] => US [patent_app_date] => 2014-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 38159 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15033715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11040483 [patent_doc_number] => 20160237440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'siRNA AND THEIR USE IN METHODS AND COMPOSITIONS FOR INHIBITING THE EXPRESSION OF THE PDK1 GENE' [patent_app_type] => utility [patent_app_number] => 15/030188 [patent_app_country] => US [patent_app_date] => 2014-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 13089 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12044765 [patent_doc_number] => 09822358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-21 [patent_title] => 'Treatment of cancers with micro-RNA inhibitors' [patent_app_type] => utility [patent_app_number] => 14/517514 [patent_app_country] => US [patent_app_date] => 2014-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 114 [patent_figures_cnt] => 117 [patent_no_of_words] => 21611 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14517514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11040476 [patent_doc_number] => 20160237432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'METHODS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPT' [patent_app_type] => utility [patent_app_number] => 15/029210 [patent_app_country] => US [patent_app_date] => 2014-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25478 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10255124 [patent_doc_number] => 20150140120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'STABILIZED APTAMERS TO PLATELET DERIVED GROWTH FACTOR AND THEIR USE AS ONCOLOGY THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 14/505776 [patent_app_country] => US [patent_app_date] => 2014-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 42229 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14505776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11068002 [patent_doc_number] => 20160264966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-15 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE' [patent_app_type] => utility [patent_app_number] => 15/026897 [patent_app_country] => US [patent_app_date] => 2014-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 56682 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11364378 [patent_doc_number] => 20170002360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'PROTEIN PHOSPHATASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 15/026038 [patent_app_country] => US [patent_app_date] => 2014-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6440 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12449220 [patent_doc_number] => 09982260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-29 [patent_title] => Identification of structurally similar small molecules that enhance therapeutic exon skipping [patent_app_type] => utility [patent_app_number] => 15/025952 [patent_app_country] => US [patent_app_date] => 2014-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 10 [patent_no_of_words] => 15784 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15025952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11040474 [patent_doc_number] => 20160237430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'ALLELE-SPECIFIC RNA SILENCING FOR THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY' [patent_app_type] => utility [patent_app_number] => 15/024288 [patent_app_country] => US [patent_app_date] => 2014-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 71 [patent_no_of_words] => 19755 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13026807 [patent_doc_number] => 10036020 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-31 [patent_title] => Compositions and methods for inhibiting JC virus (JCV) [patent_app_type] => utility [patent_app_number] => 15/023352 [patent_app_country] => US [patent_app_date] => 2014-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 39 [patent_no_of_words] => 17725 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9930926 [patent_doc_number] => 20150079118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'MicroRNA Treatment for Asthma' [patent_app_type] => utility [patent_app_number] => 14/490280 [patent_app_country] => US [patent_app_date] => 2014-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8625 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14490280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9902135 [patent_doc_number] => 20150057336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA' [patent_app_type] => utility [patent_app_number] => 14/484972 [patent_app_country] => US [patent_app_date] => 2014-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13230 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14484972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11076004 [patent_doc_number] => 20160272968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'Targeting microRNA-26a/b for the Treatment of Neurodegenerative Disease' [patent_app_type] => utility [patent_app_number] => 14/917065 [patent_app_country] => US [patent_app_date] => 2014-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25646 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12286756 [patent_doc_number] => 09932579 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-03 [patent_title] => Prevention and treatment of Nosema disease in bees [patent_app_type] => utility [patent_app_number] => 14/474205 [patent_app_country] => US [patent_app_date] => 2014-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14752 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14474205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11011297 [patent_doc_number] => 20160208250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'THERAPEUTIC AGENT FOR CORNEAL EPITHELIAL DISORDER' [patent_app_type] => utility [patent_app_number] => 14/914962 [patent_app_country] => US [patent_app_date] => 2014-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9073 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10187723 [patent_doc_number] => 09217134 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-12-22 [patent_title] => 'Aptamer drug for detoxification of Staphylococcus aureus alpha-toxin' [patent_app_type] => utility [patent_app_number] => 14/470506 [patent_app_country] => US [patent_app_date] => 2014-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8479 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14470506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9895542 [patent_doc_number] => 20150050738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING RNA' [patent_app_type] => utility [patent_app_number] => 14/461317 [patent_app_country] => US [patent_app_date] => 2014-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 80 [patent_no_of_words] => 57725 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14461317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11076001 [patent_doc_number] => 20160272966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'Method of using a miR172 Molecule for Decreasing Inflammation' [patent_app_type] => utility [patent_app_number] => 14/913650 [patent_app_country] => US [patent_app_date] => 2014-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7062 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913650 [rel_patent_id] =>[rel_patent_doc_number] =>)